← All trials
NCT05740449
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2023
- Primary completion
- Oct 1, 2029
- Completion date
- Oct 1, 2029
- First posted
- Feb 23, 2023
- Last posted
- Feb 24, 2023
- Enrollment
- 26
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Princess Maxima Center for Pediatric OncologyLead sponsor
- Humboldt UniversityOverall official - principal investigator
- Innovative Therapies For Children with Cancer ConsortiumCollaborator
- Princess Maxima Center for Pediatric OncologyStudy chair
- Fight Kids CancerCollaborator
- Humboldt UniversityOfficial
- Princess Maxima Center for Pediatric OncologyOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.